Clinical Coagulation, Malmö
101 – 120 of 629
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach
(
- Contribution to journal › Article
-
Mark
Clinical pre-test probability adjusted versus age-adjusted D-dimer interpretation strategy for DVT diagnosis : A diagnostic individual patient data meta-analysis
(
- Contribution to journal › Article
-
Mark
Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings
(
- Contribution to journal › Article
-
Mark
Jugular Vein Thrombosis and Anticoagulation Therapy in Lemierre’s Syndrome—A Post Hoc Observational and Population-Based Study of 82 Patients
2020) In Open Forum Infectious Diseases(
- Contribution to journal › Article
-
Mark
Direct comparison of two extended half-life PEGylated recombinant FVIII products : a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
(
- Contribution to journal › Article
-
Mark
A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family
(
- Contribution to journal › Article
-
Mark
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of dronedarone by atrial fibrillation history duration : Insights from the ATHENA study
(
- Contribution to journal › Article
-
Mark
Genetic risk factors for venous thromboembolism
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Evolution of replacement therapy for von Willebrand disease : From plasma fraction to recombinant von Willebrand factor
(
- Contribution to journal › Scientific review
-
Mark
Direct comparison of two extended-half-life recombinant FVIII products : a randomized, crossover pharmacokinetic study in patients with severe hemophilia A
(
- Contribution to journal › Article
-
Mark
A personalized approach to the management of VWD
(
- Contribution to journal › Article
-
Mark
Joint comorbidities among Swedish carriers of haemophilia : A register-based cohort study over 22 years
(
- Contribution to journal › Article
-
Mark
Hypertension and cardiovascular diseases in Swedish persons with haemophilia — A longitudinal registry study
(
- Contribution to journal › Article
-
Mark
Irregular dietary habits with a high intake of cereals and sweets are associated with more severe gastrointestinal symptoms in IBS patients.
(
- Contribution to journal › Article
-
Mark
ROTEM and vitro reversal of warfarin with APCC
(
- Contribution to journal › Article
-
Mark
The Coagulopathy of Acute Type A Aortic Dissection : A Prospective, Observational Study
(
- Contribution to journal › Article
-
Mark
Factor VIII : Long-established role in haemophilia A and emerging evidence beyond haemostasis
(
- Contribution to journal › Scientific review
-
Mark
The role of von Willebrand factor in acute type A aortic dissection and aortic surgery
(
- Contribution to journal › Article
-
Mark
Risk prediction of recurrent venous thromboembolism : a multiple genetic risk model
(
- Contribution to journal › Article